Zobrazeno 1 - 10
of 13
pro vyhledávání: '"M. A. Gappoeva"'
Autor:
D. A. Kharagezov, Yu. N. Lazutin, E. A. Mirzoyan, A. G. Milakin, O. N. Stateshny, I. A. Leyman, M. A. Gappoeva, V. N. Vitkovskaya, K. D. Iozefi
Publikováno v:
Южно-Российский онкологический журнал, Vol 3, Iss 2, Pp 41-51 (2022)
Lung cancer (LC) takes the first place in the structure of overall oncology in males. More than 1.8 million of new cases of lung cancer (LC) are registered each year worldwide. LC is the leading cause of cancer death in both developing and developed
Externí odkaz:
https://doaj.org/article/5cf8c576bba64630b0ab78a81f6d2e53
Autor:
K. D. Iozefi, D. A. Kharagezov, Yu. N. Lazutin, O. N. Stateshny, A. G. Milakin, I. A. Leyman, T. G. Ayrapetova, V. N. Vitkovskaya, M. A. Gappoeva, E. A. Mirzoyan, M. A. Khomidov, A. N. Shevchenko, S. N. Dimitriadi
Publikováno v:
South Russian Journal of Cancer. 4:79-93
Lung resection is the main diagnostic and therapeutic surgical intervention in terms of lung cancer management. Air leak through pleural drains often occurs after lung resections due to damage to the pulmonary parenchyma. Therefore, proper drainage o
Autor:
Elena A. Karnauhova, Denis S. Kutilin, Elena V. Filatova, Alexey N. Shevchenko, M. A. Gappoeva, Lyudmila Ya. Rozenko, Aliya K. Donskaya, Mikhail S. Zinkovich, Natalya B. Fatkina, Anna A. Solntseva, Julia N. Krokhmal, Marina A. Gusareva, Irina A. Udalenkova, Irina A. Khomutenko, Aleksandr V. Faenson, Ekaterina O. Vasilieva
Publikováno v:
Journal of Clinical Oncology. 39:e15014-e15014
e15014 Background: Radiotherapy (RT) is one of the main treatments for prostate cancer (PC). The effectiveness of such therapy depends on the initial radioresistance of tumor cells, which is ensured by their certain molecular features, which include
Autor:
M. A. Gappoeva, Aleksandr B. Sagakyants, Elena P. Ulianova, Inna Arnoldovna Novikova, Evgeniya M. Nepomnyashchaya, Maria Ezhova, Maksim N. Chernyak
Publikováno v:
Journal of Clinical Oncology. 39:e15526-e15526
e15526 Background: Colorectal cancer (CRC) is among the most common cancers. The leading cause of high mortality is tumor progression developed due to the epithelial to mesenchymal transition (EMT). The ZEB1 protein is one of the critical regulators
Autor:
Igor N. Turkin, Yuriy N. Lazutin, Oleg N. Stateshny, Anna V. Chubaryan, Igor A. Leyman, Oleg I. Kit, M. A. Gappoeva, Denis S. Kutilin, Pavel A. Anistratov
Publikováno v:
Journal of Clinical Oncology. 37:e14502-e14502
e14502 Background: Currently known markers of lung adenocarcinoma are insufficient to predict the development of this disease, which makes the search for new molecular markers a relevant problem. Our purpose was to analyze changes in genes copy numbe
Autor:
Oleg N. Stateshny, Sergey P. Pyltsin, M. Afaunov, Igor A. Leyman, S. G. Beleckiy, A. S. Shogenov, Anna V. Chubaryan, Tamara G. Ayrapetova, M. A. Gappoeva, Liubov Yu Vladimirova, Yuri Lazutin, Igor N. Turkin, Rukiyat Isaeva, Pavel A. Anistratov
Publikováno v:
Journal of Clinical Oncology. 36:8534-8534
8534Background: The purpose of the study was to compare the results of neoadjuvant polychemoimmunotherapy (nPCIT) and conventional neoadjuvant polychemotherapy (nPCT) in patients with NSCLC. Method...
Autor:
Oleg N. Stateshny, Liubov Yu Vladimirova, A. S. Shogenov, Igor N. Turkin, Yuri Lazutin, M. A. Gappoeva, Rukiyat Isaeva, M. Afaunov, Tamara G. Ayrapetova, S. G. Beleckiy, Pavel A. Anistratov, Igor A. Leyman, Sergey P. Pyltsin, Anna V. Chubaryan
Publikováno v:
Journal of Clinical Oncology. 36:e24323-e24323
e24323Background: The purpose of the study was to reveal morphological changes in tissues of NSCLC after various nPCT regimens. Methods: The study included 64 pts with stage IIb-IIIa NSCLC divided ...
Publikováno v:
Biochemistry (Moscow). 68:696-702
The role of NMDA receptors in molecular mechanisms of neurotoxicity was investigated using rat models of global and focal cerebral ischemia. Expression of NR2A and NR2B receptor mRNAs up-regulated in cortex after 3 h of reperfusion following middle c
Autor:
A. S. Shogenov, Andrey Vladimirovich Bakhtin, Tamara G. Ayrapetova, Galina I. Zakora, Inna Arnoldovna Novikova, Olesya N. Selyutina, M. A. Gappoeva, M. Kh. Afaunov, Pavel A. Anistratov, Elena Yurievna Zlatnik, Sergey P. Pyltsin, Anna V. Chubaryan, Yuriy N. Lazutin, Igor A. Leyman
Publikováno v:
Journal of Clinical Oncology. 35:e20018-e20018
e20018 Background: The purpose of the study was to evaluate parameters of cellular immunity in lung cancer patients with various levels of circulating tumor cells (CTCs) and different tumor histogenesis. Methods: Blood samples of 28 patients (24 men,
Autor:
Igor A. Leyman, M. Kh. Afaunov, Yuriy N. Lazutin, M. A. Gappoeva, Pavel A. Anistratov, Tamara G. Ayrapetova, A. S. Shogenov, Anna V. Chubaryan, Sergey P. Pyltsin
Publikováno v:
Journal of Clinical Oncology. 35:e20090-e20090
e20090 Background: We performed a comparative analysis of disease-free survival (DFS) after adjuvant chemoimmunotherapy (ACIT) with recombinant interferon-gamma in combination therapy and standard adjuvant chemotherapy (ACT) of patients with acinar-t